Amn Healthcare Stock Price, News & Analysis

symplr has acquired Smart Square® scheduling software from AMN Healthcare (NYSE: AMN), enhancing its healthcare workforce management capabilities. The acquisition combines two Best in KLAS solutions, integrating Smart Square's AI-driven nurse and staff scheduling platform with symplr's existing healthcare operations software suite.

The strategic acquisition strengthens symplr's Operations Platform by adding advanced features including predictive analytics, real-time staffing adjustments, open-shift management, and nurse competency integration. Additionally, symplr and AMN Healthcare have established a commercial partnership to leverage their respective strengths in operational technology and healthcare workforce solutions.

Following the deal, AMN Healthcare will focus on developing its Workwise platform for workforce advisory, planning AI, staffing, and analytics solutions.

AMN Healthcare (NYSE: AMN), a leader in healthcare total talent solutions, has announced the appointment of Celia Huber to its Board of Directors, effective May 2, 2025. Huber, currently a Senior Partner at McKinsey & Company, brings over 30 years of experience in healthcare strategy and leadership.

As the leader of McKinsey's Board Services Practice in North America, Huber specializes in advising Fortune 500 boards on governance, succession planning, and organizational transformation. Her extensive background includes counseling healthcare systems and payors on strategy, merger integration, and risk management.

Huber currently serves on the AltaMed Foundation board and the Executive Committee of the California Business Roundtable, demonstrating her commitment to healthcare leadership and organizational governance.

A new survey by AMN Healthcare reveals a significant increase in physician appointment wait times across 15 major U.S. metropolitan areas. The average wait time has surged to 31 days, marking a 19% increase since 2022 and a 48% increase since 2004. Among specialties, Obstetrics/Gynecology has the longest average wait time at 42 days, followed by Gastroenterology (40 days) and Dermatology (36.5 days). Boston has the highest average wait time at 65 days, while Atlanta has the shortest at 12 days. The survey also found that 82% of physicians accept Medicare, but only 53% accept Medicaid. Some extreme cases include wait times of 291 days for dermatology in Portland and 231 days for obstetrics/gynecology in Boston.

AMN Healthcare's 2025 Survey of Registered Nurses reveals significant challenges facing the nursing profession. Based on responses from 12,000+ nurses, the survey shows that while 75% are satisfied with their career choice, 58% report burnout most days and only 39% plan to stay in their current positions within 12 months. Critical findings include: 33% of nurses are eligible for retirement, 64% experience compassion fatigue, and 49% feel undervalued by employers. The survey highlights demands for workplace improvements, with 81% citing flexible schedules as a potential solution. Only 34% currently have self-scheduling options. AMN Healthcare emphasizes the need for systemic changes, including advanced scheduling technologies, mentorship programs, and workplace violence prevention measures to address these challenges and improve nurse retention.

AMN Healthcare (NYSE: AMN) reported Q1 2025 financial results with revenue of $690 million, down 16% year-over-year. The company posted a GAAP loss of ($0.03) per share and adjusted EPS of $0.45. Key segment performance included: Nurse and Allied Solutions revenue at $413M (down 20% YoY), Physician and Leadership Solutions at $174M (down 8% YoY), and Technology and Workforce Solutions at $102M (down 9% YoY). Despite challenges, Q1 results exceeded guidance, with strong cash flow from operations at $93M. The company reduced debt by $60M, ending with a net leverage ratio of 3.1:1. For Q2 2025, AMN projects revenue between $645-660M, representing an 11-13% YoY decline.

AMN Healthcare Services (NYSE: AMN) has announced its upcoming first quarter 2025 earnings conference call, scheduled for Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. The company plans to release its Q1 2025 financial results and Q2 2025 outlook after market close at approximately 4:15 p.m. Eastern Time on the same day.

Investors can access the call through a webcast link or participate via telephone by registering online to receive dial-in instructions. A replay of the webcast will be available on the company's investor relations website following the call.

AMN Healthcare's B.E. Smith division has released its 2025 Healthcare Leadership Trends survey, revealing significant turnover intentions among healthcare executives. The study, based on 588 responses from healthcare leaders nationwide, shows that 46% plan to leave their organizations within the next year, with 26% intending to depart within six months.

The survey highlights concerning workforce trends, with 74% of executives receiving credible job offers in the past six months. Notably, 80% of respondents indicate that filling executive positions is challenging in the current market. The study identifies key growth areas in leadership roles, particularly in technology management, cybersecurity, and artificial intelligence.

Financial pressures and workforce issues emerge as primary disruptors for 2025. Healthcare facilities are focusing on revenue growth through expanding existing service lines, implementing cost reductions, and adding new services. The outlook remains cautiously optimistic, with 34% expecting better conditions in 2025, 48% anticipating no change, and 18% projecting worse conditions at their facilities.

AMN Healthcare reported Q4 2024 revenue of $735 million, down 10% year-over-year but up 7% from previous quarter. The company posted a Q4 net loss of ($4.90) per share, primarily due to a $222 million non-cash goodwill impairment charge. Adjusted EPS was $0.75.

Key segment performance: Nurse and Allied Solutions revenue was $455 million (down 15% YoY), Physician and Leadership Solutions revenue was $173 million (up 3% YoY), and Technology and Workforce Solutions revenue was $107 million (down 5% YoY).

Full year 2024 results showed consolidated revenue of $2.984 billion, a 21% decrease from 2023. The company reduced debt by $75 million in Q4, bringing full-year repayment to $250 million. Cash flow from operations was $73 million for Q4 and $320 million for the year.

AMN Healthcare's Smart Square® has been awarded the 2025 Best in KLAS Scheduling: Nurse & Staff award, maintaining its highest ranking among competitors throughout 2024. The workforce management technology received top marks in categories including Culture, Operations, and Value according to the 2025 Best in KLAS Awards report.

Smart Square's success is attributed to its ability to provide precise staffing forecasts, enterprise-wide transparency, and continuous improvement guidance. The solution helps healthcare organizations optimize workforce utilization, enhance staff satisfaction, improve outcomes, and achieve cost savings.

Meredith Lapointe, Chief Business Officer at AMN Healthcare, acknowledged the important role of client feedback in achieving this recognition, emphasizing the company's dedication to innovation and excellence in workforce technology. KLAS Research's RCM/Business Solutions Research Director, Niel Oscarson, highlighted how Smart Square empowers healthcare organizations with actionable insights and effective workforce management tools.